{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:21:58Z","timestamp":1768033318809,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["CPRITRR170008"],"award-info":[{"award-number":["CPRITRR170008"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007130","name":"University of Texas System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jtct.2023.10.016","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T11:50:27Z","timestamp":1698321027000},"page":"71.e1-71.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Esther","family":"Bachar-Lustig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaf","family":"Lask","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaki","family":"Eidelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noga","family":"Or-Geva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotem","family":"Gidron-Budovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bar","family":"Nathansohn-Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Eyrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hsin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Castro","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indreshpal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Shpall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avichai","family":"Shimoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivan","family":"Barnees-Kagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.10.016_bib0001","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2012-07-441493","article-title":"Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells","volume":"121","author":"Ophir","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.016_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1074-7613(00)00050-9","article-title":"Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite","volume":"13","author":"Reich-Zeliger","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2023.10.016_bib0003","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.4049\/jimmunol.173.11.6660","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/TP.0b013e3181e86b28","article-title":"Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation","volume":"90","author":"Reich-Zeliger","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.10.016_bib0005","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2023.10.016_bib0006","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/bmt.2015.139","article-title":"Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies","volume":"50","author":"Triplett","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.016_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1009143","article-title":"Selective depletion of na\u00efve T cells by targeting CD45RA","volume":"12","author":"Naik","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0008","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/s41375-019-0501-1","article-title":"Next-generation CD8 memory veto T cells directed against memory antigens","volume":"33","author":"Or-Geva","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.10.016_bib0009","year":"1976","journal-title":"NIAID Manual of Tissue Typing Techniques"},{"key":"10.1016\/j.jtct.2023.10.016_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.1980.tb00318.x","article-title":"Quantitation and cloning of cytolytic T lymphocytes and their precursors","volume":"51","author":"MacDonald","year":"1980","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtct.2023.10.016_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrclinonc.2015.234","article-title":"Modern approaches to HLA-haploidentical blood or marrow transplantation","volume":"13","author":"Kanakry","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0012","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.016_bib0013","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1182\/blood-2011-07-338822","article-title":"Haploidentical hematopoietic transplantation: current status and future perspectives","volume":"118","author":"Reisner","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.016_bib0014","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00007890-199805270-00017","article-title":"Tolerance induction by \"megadose\" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture","volume":"65","author":"Rachamim","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.10.016_bib0015","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood.V99.11.4174","article-title":"Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells","volume":"99","author":"Gur","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.016_bib0016","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/287544a0","article-title":"An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it","volume":"287","author":"Miller","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2023.10.016_bib0017","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1084\/jem.160.6.1702","article-title":"Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity","volume":"160","author":"Cla\u00ebsson","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2023.10.016_bib0018","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.4049\/jimmunol.173.11.6654","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MOT.0000000000000095","article-title":"Megadose stem cell administration as a route to mixed chimerism","volume":"19","author":"Or-Geva","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jtct.2023.10.016_bib0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.133.4.1769","article-title":"Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes","volume":"133","author":"Fink","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0021","first-page":"213","article-title":"Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures","volume":"126","author":"Claesson","year":"1986","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.iy.06.040188.000555","article-title":"Veto cells","volume":"6","author":"Fink","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0023","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-3083.1989.tb01150.x","article-title":"Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. III. Direct correlation between development of syngeneic cytotoxicity and loss of veto activity; implications for the mechanism of veto action","volume":"29","author":"Claesson","year":"1989","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0024","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2009-10-248716","article-title":"Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells","volume":"115","author":"Ophir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.016_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2007.07.001","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced-intensity conditioning: an update","volume":"40","author":"Bethge","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtct.2023.10.016_bib0026","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease","volume":"68","author":"Kernan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.016_bib0027","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alfa beta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.10.016_bib0028","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2022-159183","article-title":"First in human study of anti-viral veto cells enabling successful engraftment without severe GvHD in non-myeloablative T cell-depleted haploidentical hematopoietic stem cell transplantation (HSCT)","volume":"140","author":"Champlin","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.016_bib0029","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2023.10.016_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","article-title":"Strategies of adoptive T cell transfer to treat refractory viral infections post allogeneic stem cell transplantation","volume":"12","author":"Kaeuferle","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.10.016_bib0031","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI121127","article-title":"Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation","volume":"130","author":"Prockop","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2023.10.016_bib0032","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/leu.2017.332","article-title":"Towards \u201coff-the-shelf\u201d genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells","volume":"32","author":"Or-Geva","year":"2018","journal-title":"Leukemia"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672301638X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672301638X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:57Z","timestamp":1763003517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672301638X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S266663672301638X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}